Triochem Products Ltd
Triochem Products engaged primarily in the business of manufacturer and exporter of pharlnaceuticals products, Apls and chemicals.
- Market Cap ₹ Cr.
- Current Price ₹ 17.4
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 843
- Dividend Yield 0.00 %
- ROCE -4.37 %
- ROE -34.6 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.02 times its book value
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -15.6% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.68 | 23.11 | 18.06 | 34.99 | 12.35 | 20.03 | 13.94 | 8.82 | 0.00 | 0.00 | -0.01 | -0.03 | 0.00 | |
| 29.44 | 22.11 | 17.07 | 31.18 | 10.71 | 15.48 | 14.30 | 7.47 | 1.33 | 1.05 | 1.21 | 1.34 | 1.08 | |
| Operating Profit | 1.24 | 1.00 | 0.99 | 3.81 | 1.64 | 4.55 | -0.36 | 1.35 | -1.33 | -1.05 | -1.22 | -1.37 | -1.08 |
| OPM % | 4.04% | 4.33% | 5.48% | 10.89% | 13.28% | 22.72% | -2.58% | 15.31% | |||||
| 0.08 | -0.01 | 0.16 | 0.41 | 0.06 | 0.47 | 0.13 | 0.55 | 0.27 | -0.19 | 1.05 | 12.03 | 11.98 | |
| Interest | 0.45 | 0.20 | 0.07 | 0.40 | 0.46 | 0.30 | 0.21 | 0.02 | 0.00 | 0.00 | 0.00 | 0.10 | 0.08 |
| Depreciation | 0.32 | 0.27 | 0.28 | 0.25 | 0.21 | 0.17 | 0.14 | 0.12 | 0.11 | 0.09 | 0.08 | 0.05 | 0.03 |
| Profit before tax | 0.55 | 0.52 | 0.80 | 3.57 | 1.03 | 4.55 | -0.58 | 1.76 | -1.17 | -1.33 | -0.25 | 10.51 | 10.79 |
| Tax % | 23.64% | 32.69% | 28.75% | 28.57% | 29.13% | 25.27% | -24.14% | 25.00% | -24.79% | -24.06% | 60.00% | 24.17% | |
| 0.42 | 0.34 | 0.58 | 2.56 | 0.74 | 3.40 | -0.45 | 1.32 | -0.89 | -1.01 | -0.40 | 7.97 | 8.10 | |
| EPS in Rs | 17.14 | 13.88 | 23.67 | 104.49 | 30.20 | 138.78 | -18.37 | 53.88 | -36.33 | -41.22 | -16.33 | 325.31 | 330.60 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 200% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -10% |
| 3 Years: | -16% |
| Last Year: | -35% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Reserves | 4.31 | 4.65 | 5.24 | 7.79 | 8.53 | 11.93 | 11.47 | 12.80 | 11.35 | 14.38 | 13.42 | 20.40 |
| 3.50 | 0.00 | 2.86 | 2.28 | 5.79 | 2.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.42 | 2.12 | 1.93 | 1.47 | 0.58 | 1.94 | 0.38 | 0.28 | 0.24 | 0.25 | 0.23 | 0.23 | |
| Total Liabilities | 8.48 | 7.02 | 10.28 | 11.79 | 15.15 | 16.62 | 12.10 | 13.33 | 11.84 | 14.88 | 13.90 | 20.88 |
| 1.72 | 1.85 | 1.64 | 1.42 | 1.22 | 1.06 | 0.94 | 0.87 | 0.77 | 0.68 | 0.60 | 0.00 | |
| CWIP | 0.37 | 0.04 | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.12 | 3.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.42 | 11.07 | 10.63 | 7.89 |
| 6.27 | 1.45 | 8.64 | 10.37 | 13.93 | 15.53 | 11.13 | 12.46 | 1.65 | 3.13 | 2.67 | 12.99 | |
| Total Assets | 8.48 | 7.02 | 10.28 | 11.79 | 15.15 | 16.62 | 12.10 | 13.33 | 11.84 | 14.88 | 13.90 | 20.88 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.34 | 6.79 | -6.48 | 1.45 | -3.75 | 3.82 | 10.25 | 3.47 | -1.03 | -3.76 | 0.20 | -2.87 | |
| -0.10 | -3.70 | 3.71 | -0.01 | 0.02 | -0.03 | 0.00 | 0.16 | -9.82 | 3.34 | 0.17 | 13.70 | |
| -1.69 | -3.68 | 2.80 | -0.92 | 3.06 | -3.49 | -2.61 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | 0.56 | -0.59 | 0.03 | 0.52 | -0.67 | 0.30 | 7.64 | 3.61 | -10.85 | -0.42 | 0.37 | 10.82 |
| Free Cash Flow | 2.24 | 6.68 | -6.51 | 1.42 | -3.76 | 3.79 | 10.23 | 3.44 | -1.03 | -3.76 | 0.20 | 8.85 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 241% | 682% | -635% | 56% | -176% | 106% | -2,939% | 287% | 105% | 351% | -17% | 64% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 2.02 | 0.00 | 49.52 | 0.00 | 98.42 | 225.96 | 36.40 | 0.00 | 0.00 | 0.00 | ||
| Inventory Days | 55.65 | 5.85 | 52.93 | 104.38 | 414.36 | 41.57 | 24.60 | 2.90 | 0.00 | 0.00 | ||
| Days Payable | 1.45 | 31.02 | 36.57 | 9.13 | 14.72 | 19.85 | 9.26 | 9.85 | ||||
| Cash Conversion Cycle | 56.22 | -25.17 | 65.88 | 95.24 | 498.06 | 247.68 | 51.74 | -6.95 | 0.00 | 0.00 | ||
| Working Capital Days | 16.06 | -19.43 | 63.06 | 56.23 | 216.64 | 190.79 | 63.10 | 0.83 | 50,735.00 | 14,965.00 | ||
| ROCE % | 11.78% | 11.57% | 12.83% | 42.53% | 11.97% | 33.16% | -2.80% | 14.45% | -10.14% | -2.67% | -3.32% | -4.37% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Electricity Consumption units |
|
|||||
| Export Earnings (Foreign Exchange Earnings) Rs. lakhs |
||||||
| Import Outgo (Foreign Exchange Outgo) Rs. lakhs |
||||||
| Sales to G Amphray Laboratories (Related Party) Rs. lakhs |
||||||
| Furnace Oil Consumption litres |
||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Board Of Director Meeting Of Triochem Products Limited Will Meet On Wednesday, 4Th November 2026 At 03.00 P.M. At The Registered Office Of Company
- Board meets 4 November 2026 to approve Q2 and half-year results; trading window closed from 1 October.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Submitted Regulation 74(5) dematerialisation certificate for quarter ended 30 September 2026.
-
Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount For Loans
Including Revolving Facilities Like Cash Credit From Banks / Financial Institutions
- Triochem Products reported nil debt and nil defaults for quarter ended 30 September 2026.
- Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt Securities
-
Compliance-57 (5) : intimation after the end of quarter
- Quarterly interest/dividend certificate filing not applicable as no non-convertible securities are issued.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse